Factors associated with antithrombotic treatment decisions for stroke prevention in atrial fibrillation in the Stockholm region after the introduction of NOACs

Por Komen, Joris, Forslund, Tomas, Hjemdahl, Paul, Wettermark, Björn
Publicado no Eur J Clin Pharmacol (2017)

Concomitant use of two or more antipsychotic drugs is common in Sweden

Por Bergendal, Annica, Schiöler, Helena, Wettermark, Björn, Björkstén, Karin Sparring
Publicado no Ther Adv Psychopharmacol (2015)

Health care use, drug treatment and comorbidity in patients with schizophrenia or non-affective psychosis in Sweden: a cross-sectional study

Por Brostedt, Erica M., Msghina, Mussie, Persson, Marie, Wettermark, Björn
Publicado no BMC Psychiatry (2017)

Usage, Risk, and Benefit of Weight-Loss Drugs in Primary Care

Por Forslund, Tomas, Raaschou, Pauline, Hjemdahl, Paul, Krakau, Ingvar, Wettermark, Björn
Publicado em 2011

Effects of policy interventions on the introduction of novel oral anticoagulants in Stockholm: an interrupted time series analysis

Por Komen, Joris, Forslund, Tomas, Hjemdahl, Paul, Andersen, Morten, Wettermark, Björn
Publicado no Br J Clin Pharmacol (2016)

Time trends in statin utilisation and coronary mortality in Western European countries

Por Vancheri, Federico, Backlund, Lars, Strender, Lars-Erik, Godman, Brian, Wettermark, Björn
Publicado no BMJ Open (2016)

Differences in drug utilisation between men and women: a cross-sectional analysis of all dispensed drugs in Sweden

Por Loikas, Desirée, Wettermark, Björn, von Euler, Mia, Bergman, Ulf, Schenck-Gustafsson, Karin
Publicado em 2013

Healthcare Utilisation and Drug Treatment in a Large Cohort of Patients with Inflammatory Bowel Disease

Por Cars, Thomas, Wettermark, Björn, Löfberg, Robert, Eriksson, Irene, Sundström, Johan, Lördal, Mikael
Publicado no J Crohns Colitis (2016)

Nationwide drug-dispensing data reveal important differences in adherence to drug label recommendations on CYP2D6-dependent drug interactions

Por Mannheimer, Buster, Wettermark, Björn, Lundberg, Michael, Pettersson, Hans, von Bahr, Christer, Eliasson, Erik
Publicado em 2010

High prevalence of diagnosis of diabetes, depression, anxiety, hypertension, asthma and COPD in the total population of Stockholm, Sweden – a challenge for public health

Por Carlsson, Axel C, Wändell, Per, Ösby, Urban, Zarrinkoub, Ramin, Wettermark, Björn, Ljunggren, Gunnar
Publicado em 2013

O01 - Validation of asthma and eczema in population-based Swedish health registers

Por Örtqvist, Anne K, Lundholm, Cecilia, Wettermark, Björn, Ludvigsson, Jonas F, Ye, Weimin, Almqvist, Catarina
Publicado em 2014

Antibiotic use and bacterial complications following upper respiratory tract infections: a population-based study

Por Cars, Thomas, Eriksson, Irene, Granath, Anna, Wettermark, Björn, Hellman, Jenny, Norman, Christer, Ternhag, Anders
Publicado no BMJ Open (2017)

Persistence with dimethyl fumarate in relapsing-remitting multiple sclerosis: a population-based cohort study

Por Eriksson, Irene, Cars, Thomas, Piehl, Fredrik, Malmström, Rickard E., Wettermark, Björn, von Euler, Mia
Publicado no Eur J Clin Pharmacol (2017)

The changing multiple sclerosis treatment landscape: impact of new drugs and treatment recommendations

Por Eriksson, Irene, Komen, Joris, Piehl, Fredrik, Malmström, Rickard E., Wettermark, Björn, von Euler, Mia
Publicado no Eur J Clin Pharmacol (2018)

Trends in medicines procurement by the Brazilian federal government from 2006 to 2013

Por Chama Borges Luz, Tatiana, Garcia Serpa Osorio-de-Castro, Claudia, Magarinos-Torres, Rachel, Wettermark, Bjorn
Publicado no PLoS One (2017)

Pro-Arrhythmic Potential of Oral Antihistamines (H1): Combining Adverse Event Reports with Drug Utilization Data across Europe

Por Poluzzi, Elisabetta, Raschi, Emanuel, Godman, Brian, Koci, Ariola, Moretti, Ugo, Kalaba, Marija, Wettermark, Bjorn, Sturkenboom, Miriam, De Ponti, Fabrizio
Publicado no PLoS One (2015)

Persistence to antihypertensive drug classes: A cohort study using the Swedish Primary Care Cardiovascular Database (SPCCD)

Por Qvarnström, Miriam, Kahan, Thomas, Kieler, Helle, Brandt, Lena, Hasselström, Jan, Boström, Kristina Bengtsson, Manhem, Karin, Hjerpe, Per, Wettermark, Björn
Publicado no Medicine (Baltimore) (2016)

Forecasting drug utilization and expenditure in a metropolitan health region

Por Wettermark, Björn, Persson, Marie E, Wilking, Nils, Kalin, Mats, Korkmaz, Seher, Hjemdahl, Paul, Godman, Brian, Petzold, Max, Gustafsson, Lars L
Publicado em 2010

The Stockholm CREAtinine Measurements (SCREAM) project: protocol overview and regional representativeness

Por Runesson, Björn, Gasparini, Alessandro, Qureshi, Abdul Rashid, Norin, Olof, Evans, Marie, Barany, Peter, Wettermark, Björn, Elinder, Carl Gustaf, Carrero, Juan Jesús
Publicado no Clin Kidney J (2016)

Torsadogenic Risk of Antipsychotics: Combining Adverse Event Reports with Drug Utilization Data across Europe

Por Raschi, Emanuel, Poluzzi, Elisabetta, Godman, Brian, Koci, Ariola, Moretti, Ugo, Kalaba, Marija, Bennie, Marion, Barbui, Corrado, Wettermark, Bjorn, Sturkenboom, Miriam, De Ponti, Fabrizio
Publicado em 2013